The influence of haemodialysis on CD4+ T-cell counts in people living with human immunodeficiency virus with end-stage kidney disease.

Melanie Pretorius Estee Benade June Fabian Denise Lawrie Elizabeth Sarah Mayne

Published in: Southern African journal of HIV medicine (2020)

This study showed that haemodialysis does not have an immediate negative impact on CD4+ T-cell count, suggesting that immunologic recovery is not impeded by treatment of the underlying ESKD.

Keyphrases

human immunodeficiency virus
hepatitis c virus
antiretroviral therapy
peritoneal dialysis
end stage renal disease
hiv infected
peripheral blood
chronic kidney disease
combination therapy
replacement therapy